Peter V. Danenberg
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 53
- Colorectal Cancer Treatments and Studies 31
- Cancer-related Molecular Pathways 11
-
- Cancer, Hypoxia, and Metabolism 11
- Co-authors
- Kathleen D. Danenberg (102 shared papers)Jan Brabender (29 shared papers)Heinz‐Josef Lenz (14 shared papers)Reginald V. Lord (17 shared papers)Dennis S. Salonga (21 shared papers)Charles Heidelberger (11 shared papers)Ralf Metzger (25 shared papers)Arnold Lockshin (4 shared papers)
- Journals
- Clinical Cancer Research (10 papers)Journal of Medicinal Chemistry (9 papers)Journal of Gastrointestinal Surgery (8 papers)Biochemistry (8 papers)Biochemical and Biophysical Research Communications (7 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Peter V. Danenberg
150 papers receiving 8.3k citations
Peter V. Danenberg's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 3.6k
- Cancer Research 1.4k
- Molecular Biology 3.8k
- Pulmonary and Respiratory Medicine 1.5k
- Pathology and Forensic Medicine 815
Countries citing papers authored by Peter V. Danenberg
This map shows the geographic impact of Peter V. Danenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Danenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Danenberg more than expected).
Fields of papers citing papers by Peter V. Danenberg
This network shows the impact of papers produced by Peter V. Danenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Danenberg. The network helps show where Peter V. Danenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter V. Danenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Hit paper breakdown → | 2002 | 583 |
| 2 | 2001 | 537 | |
| 3 | Thymidylate synthetase - a target enzyme in cancer chemotherapy Hit paper breakdown → | 1977 | 463 |
| 4 | 2006 | 372 | |
| 5 | Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. | 2000 | 331 |
| 6 | 2014 | 325 | |
| 7 | Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. | 2002 | 269 |
| 8 | 2000 | 204 | |
| 9 | Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. | 2001 | 200 |
| 10 | Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. | 1999 | 197 |
| 11 | p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. | 1998 | 184 |
| 12 | 1978 | 163 | |
| 13 | 1974 | 160 | |
| 14 | 2008 | 128 | |
| 15 | 1981 | 124 | |
| 16 | 2005 | 119 | |
| 17 | 2001 | 117 | |
| 18 | 2010 | 116 | |
| 19 | Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. | 1984 | 115 |
| 20 | 2002 | 109 |
About Peter V. Danenberg
Peter V. Danenberg is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Surgery, having authored 153 papers that have together received 8.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (31 papers), Biochemical and Molecular Research (25 papers), Esophageal Cancer Research and Treatment (17 papers), Genetic factors in colorectal cancer (12 papers), Cancer-related Molecular Pathways (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Inflammatory mediators and NSAID effects (8 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.4k citations), Molecular Biology (3.8k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Pathology and Forensic Medicine (815 citations). Peter V. Danenberg has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Kathleen D. Danenberg, Jan Brabender, Heinz‐Josef Lenz, Reginald V. Lord, Dennis S. Salonga, Charles Heidelberger, Ralf Metzger, Arnold Lockshin, Susan G. Groshen and Paul M. Schneider. Their work appears in journals such as Clinical Cancer Research, Journal of Medicinal Chemistry, Journal of Gastrointestinal Surgery, Biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.